Boehringer shifts focus to rapid deployment of avian influenza vaccines amid expanding virus spread
Boehringer Ingelheim highlights the transition from debating whether to vaccinate against avian influenza to how swiftly it can be integrated with biosecurity and surveillance, as the virus spreads across species and regions, posing heightened risks and trade challenges.
Boehringer Ingelheim says the debate over highly pathogenic avian influenza is moving from whether to vaccinate to how quickly vaccination can be integrated with biosecurity and surveillance. That shift matters because the virus is spreading across more species and geographies, raising the cost of inaction for poultry producers, regulators and trade partners alike.
At the company’s Global Avian Influenza Forum in Barcelona, 220 participants from 35 countries heard growing agreement that vaccination must sit alongside farm-level biosecurity and monitoring, not replace them. The discussion reflected a broader scientific view: a recent review in PubMed found H5Nx viruses have expanded well beyond wild birds and poultry to infect mammals, including humans, while keeping pace through continual genetic change.
France remains the most closely watched case study. Dr Taoufik Rawi, who leads Boehringer’s poultry franchise, said the country’s campaign has shown that vaccination can sharply reduce outbreaks and limit economic losses when paired with a surveillance system capable of identifying infected flocks.
The trade question is still the main obstacle. Boehringer argues that DIVA-compatible vaccines, which allow authorities to distinguish vaccinated birds from infected ones, make safe trade feasible if detection protocols are sufficiently sensitive. That view is echoed by the European Food Safety Authority, which has stressed that vaccination lowers viral loads and therefore demands molecular diagnostics that can still pick up residual infection.
The industry now faces a regulatory race: faster strain updates and temporary licensing routes may determine how quickly vaccination becomes routine rather than exceptional.
"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."